Trial search
Nation, Province(City)
Code of disease
Primary sponsor(s)
Secondary sponsor(s)
Funding source
Recruiting status
Register status
Measure
Ethical committee
Study type
Trial search
Public title
Scientific title
Subject ID
Registration Status
Registration number
Secondary ID
Applicant
Study leader
Year
Primary sponsor
Secondary sponsor
Source(s) of funding
Target disease
Target disease code
Study type
Study phase
Study design
Recruiting status
Execute time(From)
Execute time(END)
Sign the informed consent
Gender
Nation(Area)
Province
City
Unit (hospital)
Institution
Level of the institution
Intervention
Intervention code
Approved by ethic committee
Calculated Results after the Study
Completed puboptionc access
2
trials have been registered
| Historical versions | Registration number | Public title | Type | Registration time |
|---|---|---|---|---|
| Historical Versions | ChiCTR2400086809 |
A single-arm, multicenter, open clinical study to evaluate the efficacy and safety of Axicabtagene Ciloleucel injection as second -line treatment for adult patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
Interventional study | 2024/07/11 |
| Historical Versions | ChiCTR2400086700 |
A non-interference clinical study to evaluate the treatment of adult large B-cell lymphoma (r/r LBCL) with Axicabtagene Ciloleucel Injection that is refractory to first-line chemoimmunotherapy or relapses within 12 months of first-line chemoimmunotherapy.
Ruijin Hospital, School of Medicine, Shanghai Jiaotong University |
Observational study | 2024/07/09 |
Chinese Clinical Trial Registry, Primary Registry of WHO International Clinical Trials Registry Platform
Copyright(c) (2005 - 2023) Chictr.org.cn.All rights reserved. Chinese Clinical Trial Registry
Note: It is recommended to use the widescreen display resolution of Internet Explorer 8.0 or later